WallStreetZenWallStreetZen

NASDAQ: TCRT
Alaunos Therapeutics Inc Stock Ownership - Who owns Alaunos Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Alaunos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert W. PostmaDirector2026-07-238,463$1.92
$16.25kBuy
Holger WeisCEO2026-07-234,568$1.92
$8.77kBuy
Michael Allen JermanDirector2026-07-238,138$1.92
$15.62kBuy
Jaime VieserDirector2026-07-238,789$1.92
$16.87kBuy
Holger WeisChief Executive Officer2026-06-303,880$2.26
$8.77kBuy
Holger WeisChief Executive Officer2026-06-127,761$2.26
$17.54kBuy
Holger WeisChief Executive Officer2026-05-223,700$2.37
$8.77kBuy
Robert W. PostmaDirector2026-04-296,274$2.59
$16.25kBuy
Michael Allen JermanDirector2026-04-296,032$2.59
$15.62kBuy
Jaime VieserDirector2026-04-296,515$2.59
$16.87kBuy

1 of 2

TCRT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCRT insiders and whales buy or sell their stock.

TCRT Shareholders

What type of owners hold Alaunos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk464.88%11,056,069$21.01MInsider
Robert W. Postma186.72%4,440,637$8.44MInsider
Essex Woodlands Health Ventures Fund VI L P99.72%2,371,642$4.51MInsider
Laurence James Neil Cooper75.66%1,799,280$3.42MInsider
Paloma International L P51.07%1,214,456$2.31MInsider
Lindsay A. Md Rosenwald51.07%1,214,455$2.31MInsider
Kevin S. Boyle Sr.33.56%798,236$1.52MInsider
Jonathan 1. Lewis31.31%744,595$1.41MInsider
James Anthony Cannon16.74%398,050$756.30kInsider
Timothy McInerney15.65%372,120$707.03kInsider

1 of 3

TCRT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCRT0.45%99.55%Net BuyingNet Buying
MBIO6.70%13.37%Net Selling
LIMN3.29%61.98%
SILO82.63%17.37%Net Buying
CLGN10.60%4.63%
View Top Biotech Stocks

Alaunos Therapeutics Stock Ownership FAQ

Who owns Alaunos Therapeutics?

Alaunos Therapeutics (NASDAQ: TCRT) is owned by 5.30% institutional shareholders, 1,170.93% Alaunos Therapeutics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Alaunos Therapeutics shareholder, owning 11.06M shares representing 464.88% of the company. Randal J. Kirk's Alaunos Therapeutics shares are currently valued at $20.79M.

If you're new to stock investing, here's how to buy Alaunos Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.